Stocks / ETF
ARKGETF
ARK Genomic Revolution ETF
$51.591d +7.8%5d +13.7%settled close · 2026-09-17
β 1.8652w $28–52Shares 39.3MCboe BZX since 2014
The tape, with the calls on it
Who said what, and what ARKG did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
bullish
bearish
both sides
Who’s talkingIdea Scout · free
Who’s talking about ARKG
2 longlatest 2026-08-18
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2026-08-18 | Cathie WoodCEO & CIO, ARK Invest | Bullish | Insightful Investor | The multiomics revolution — single-cell sequencing, AI diagnostics, and CRISPR gene editing converging to… |
| 2025-06-05 | Cathie WoodCEO & CIO, ARK Invest | Bullish | Chris Davis | ARKG ETF concentrates exposure in AI-driven healthcare—early-stage cancer diagnostics, gene editing… |
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where ARKG’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 6 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-17 | ||||||
| 2026-09-14 | ||||||
| 2026-08-17 | ||||||
| 2026-07-13 | ||||||
| 2026-06-29 | ||||||
| 2026-06-09 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
ARKG is in this morning’s Brief.
Get The Brief — $20/mo →